Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Multi-omics investigation of benzo[a]pyrene in gastric cancer: comprehensive network toxicology, machine learning and
Chunhong Li1,2, Xin Zeng3, Yuhua Mao4
1Central Laboratory, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, Guangxi, China. chunhongli@glmc.edu.cn.
Abstract:
Gastric cancer (GC) risk is shaped by environmental exposures such as benzo[a]pyrene (BaP). Here, we systematically identified BaP-toxicological targets and dissected their contribution to GC development. BaP-related targets were independently predicted with stringent filters from ChEMBL, Similarity Ensemble Approach (SEA) and PharmMapper databases, while GC-related targets were mined from the Comparative Toxicogenomics Database (CTD), GeneCards and OMIM databases. Overlapping targets were subjected to protein-protein interaction (PPI) network construction, functional enrichment analysis and molecular docking. We then integrated multi-omics data using ten clustering algorithms to identify the consensus GC subtypes, which were subsequently employed 101 machine learning combinations to develop a consensus benzo[a]pyrene-related signature (CBRS) for GC patients. As a result, we identified seven hub toxicological targets: ALB, HSP90AA1, ESR1, INS, TP53, TNF, and EGFR, underscoring their potential central roles in BaP-driven GC pathogenesis. These targets are enriched in the MAPK, Lipid and atherosclerosis, and PI3K-Akt signaling pathway. The BaP-toxicological classifiers and the CBRS prognostic model could provide useful support for risk stratification and inform personalized therapeutic strategies for GC patients. Molecular docking results suggest that BaP exhibits relatively strong binding affinity with these key toxicological targets, potentially implicating their involvement in BaP-induced gastric cancer toxicity. Therefore, this study integrates multi-dimensional omics data with advanced machine learning algorithms to establish a comprehensive analytical framework for the toxicological effects of between BaP and GC, which transcends the limitations of traditional analyses and offers unprecedented insights and evidence chains for elucidating the pathogenesis of GC.
Insights
This study identifies key toxicological targets involved in benzo[a]pyrene (BaP) exposure and gastric cancer (GC) development. A novel prognostic model, the consensus benzo[a]pyrene-related signature (CBRS), aids in risk stratification for GC patients.
Area of Science:
- Toxicogenomics
- Cancer Research
- Bioinformatics
Background:
- Environmental exposures, like benzo[a]pyrene (BaP), are significant risk factors for gastric cancer (GC).
- Understanding the molecular mechanisms linking BaP exposure to GC pathogenesis is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To systematically identify BaP-toxicological targets and analyze their contribution to GC development.
- To develop a prognostic model for GC patients based on BaP-related molecular signatures.
Main Methods:
- Utilized ChEMBL, SEA, and PharmMapper databases for BaP-target prediction; CTD, GeneCards, and OMIM for GC-target identification.
- Performed protein-protein interaction network analysis, functional enrichment, and molecular docking.
- Integrated multi-omics data with clustering and machine learning algorithms to develop a consensus benzo[a]pyrene-related signature (CBRS).
Main Results:
- Identified seven hub toxicological targets (ALB, HSP90AA1, ESR1, INS, TP53, TNF, EGFR) central to BaP-driven GC pathogenesis.
- Enrichment analysis revealed involvement of MAPK, Lipid and atherosclerosis, and PI3K-Akt signaling pathways.
- Developed a CBRS prognostic model for GC patients, demonstrating BaP's binding affinity to key targets.
Conclusions:
- The identified targets and pathways provide insights into BaP-induced GC toxicity.
- The CBRS model offers a valuable tool for GC risk stratification and personalized therapy.
- This study establishes a comprehensive framework for analyzing the toxicological effects of BaP on GC.

